{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T22:09:33Z","timestamp":1768514973057,"version":"3.49.0"},"reference-count":43,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T00:00:00Z","timestamp":1605225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010438","name":"Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu","doi-asserted-by":"publisher","award":["502-14-03305411-67212"],"award-info":[{"award-number":["502-14-03305411-67212"]}],"id":[{"id":"10.13039\/501100010438","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Parenteral nutrition (PN) admixtures are prone to interacting with drugs administered intravenously via a common catheter. This may cause a threat to a patient\u2019s health and life. The literature that has been reported on the compatibility of loop diuretics with PN presents conflicting results. This work aimed to study the compatibility of furosemide and torsemide with PN used in clinical practice. Undiluted solutions of drugs were mixed with PN at various ratios determined by flow rates. In order to assess compatibility, visual control was followed by pH measurement, osmolality, mean emulsion droplet diameter (MDD), and zeta potential upon mixing and at 4 h of storage. No macroscopic changes that indicated lipid emulsion degradation were observed. After the addition of the drugs, the value of pH ranged from 6.37 \u00b1 0.01 to 7.38 \u00b1 0.01. The zeta potential was in reverse proportion to the drug concentration. The addition of the drugs did not affect the MDD. It may be suggested that the co-administration of furosemide or torsemide and PN caused no interaction. The absence of such signs of unwanted interactions allowed for the co-administration of the mentioned loop diuretics and PN at each of the studied ratios.<\/jats:p>","DOI":"10.3390\/pharmaceutics12111092","type":"journal-article","created":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T08:44:02Z","timestamp":1605257042000},"page":"1092","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Co-Administration of Drugs and Parenteral Nutrition: In Vitro Compatibility Studies of Loop Diuretics for Safer Clinical Practice"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6130-7522","authenticated-orcid":false,"given":"Szymon","family":"Tomczak","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Poznan University of Medical Sciences, 6 Grunwaldzka, 60-780 Pozna\u0144, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5106-5937","authenticated-orcid":false,"given":"Maciej","family":"Stawny","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Poznan University of Medical Sciences, 6 Grunwaldzka, 60-780 Pozna\u0144, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Jeli\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Poznan University of Medical Sciences, 6 Grunwaldzka, 60-780 Pozna\u0144, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,11,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0140-6736(06)68307-4","article-title":"Parenteral nutrition in adult inpatients with functioning gastrointestinal tracts: Assessment of outcomes","volume":"367","author":"Zaloga","year":"2006","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.clnu.2005.03.006","article-title":"Negative impact of hypocaloric feeding and energy balance on clinical outcome in ICU patients","volume":"24","author":"Villet","year":"2005","journal-title":"Clin. Nutr."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1001\/jama.2013.278481","article-title":"Acute Skeletal Muscle Wasting in Critical Illness","volume":"310","author":"Puthucheary","year":"2013","journal-title":"JAMA"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1097\/CCM.0000000000001306","article-title":"Nutritional Status and Mortality in the Critically Ill*","volume":"43","author":"Mogensen","year":"2015","journal-title":"Crit. Care Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.clnu.2017.06.025","article-title":"ESPEN guidelines on nutritional support for polymorbid internal medicine patients","volume":"37","author":"Gomes","year":"2018","journal-title":"Clin. Nutr."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.clnu.2018.08.037","article-title":"ESPEN guideline on clinical nutrition in the intensive care unit","volume":"38","author":"Singer","year":"2019","journal-title":"Clin. Nutr."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Gosty\u0144ska, A., Stawny, M., Dettlaff, K., and Jeli\u0144ska, A. (2019). Clinical nutrition of critically ill patients in the context of the latest ESPEN guidelines. Medicina, 55.","DOI":"10.3390\/medicina55120770"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Staven, V., Wang, S., Gr\u00f8nlie, I., and Tho, I. (2016). Development and evaluation of a test program for Y-site compatibility testing of total parenteral nutrition and intravenous drugs. Nutr. J., 15.","DOI":"10.1186\/s12937-016-0149-x"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Greenhill, K., Hornsby, E., and Gorman, G. (2019). Investigations of physical compatibilities of commonly used intravenous medications with and without parenteral nutrition in pediatric cardiovascular intensive care unit patients. Pharmaceuticals, 12.","DOI":"10.3390\/ph12020067"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/014860719602000181","article-title":"Fatal microvascular pulmonary emboli from precipitation of a total nutrient admixture solution","volume":"20","author":"Hill","year":"1996","journal-title":"J. Parenter. Enteral Nutr."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Bradley, J.S., Wassel, R.T., Lee, L., and Nambiar, S. (2009). Intravenous ceftriaxone and calcium in the neonate: \n\t\t  Assessing the risk for cardiopulmonary adverse events. Pediatrics, 123.","DOI":"10.1542\/peds.2008-3080"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.clnu.2008.08.011","article-title":"Fine vs. coarse complete all-in-one admixture infusions over 96 hours in rats: Fat globule size and hepatic function","volume":"27","author":"Driscoll","year":"2008","journal-title":"Clin. Nutr."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.clnu.2006.02.009","article-title":"Pathological consequences to reticuloendothelial system organs following infusion of unstable all-in-one mixtures in rats","volume":"25","author":"Driscoll","year":"2006","journal-title":"Clin. Nutr."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1136\/bmj.b814","article-title":"Errors in administration of parenteral drugs in intensive care units: Multinational prospective study","volume":"338","author":"Valentin","year":"2009","journal-title":"BMJ"},{"key":"ref_15","first-page":"47","article-title":"Prevalence of intravenous medication administration errors: A cross-sectional study","volume":"6","author":"Fekadu","year":"2017","journal-title":"Integr. Pharm. Res. Pract."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1755-7682-5-15","article-title":"Medication administration errors in an intensive care unit in Ethiopia","volume":"5","author":"Agalu","year":"2012","journal-title":"Int. Arch. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.3390\/nu5062006","article-title":"Developing and implementing all-in-one standard paediatric parenteral nutrition","volume":"5","author":"Meyer","year":"2013","journal-title":"Nutrients"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Bolisetty, S., Osborn, D., Sinn, J., Lui, K., Kent, A., Trivedi, A., Yaacoub, D., Morris, S., Marshall, P., and Birch, P. (2014). Standardised neonatal parenteral nutrition formulations\u2014An Australasian group consensus 2012. BMC Pediatr., 14.","DOI":"10.1186\/1471-2431-14-48"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Klopotowska, J.E., Kuiper, R., van Kan, H.J., de Pont, A.C., Dijkgraaf, M.G., Lie-A-Huen, L., Vroom, M.B., and Smorenburg, S.M. (2010). On-ward participation of a hospital pharmacist in a Dutch intensive care unit reduces prescribing errors and related patient harm: An intervention study. Crit. Care, 14.","DOI":"10.1186\/cc9278"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.vhri.2014.05.001","article-title":"Economic evaluation of four drug administration systems in intensive care units in Colombia","volume":"5","author":"Rosselli","year":"2014","journal-title":"Value Heal. Reg. Issues"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e093","DOI":"10.1097\/pq9.0000000000000093","article-title":"Total Parenteral Nutrition Standardization and Electronic Ordering to Reduce Errors","volume":"3","author":"Crews","year":"2018","journal-title":"Pediatr. Qual. Saf."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5049\/EBP.2015.13.1.17","article-title":"Loop Diuretics in Clinical Practice","volume":"13","author":"Oh","year":"2015","journal-title":"Electrolyte Blood Press."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijcard.2019.01.109","article-title":"Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure\u2014A multicenter propensity score matched analysis","volume":"289","author":"Grundtvig","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/0735-1097(96)00161-1","article-title":"Diuretic efficacy of high dose furosemide in severe heart failure: Bolus injection versus continuous infusion","volume":"28","author":"Dormans","year":"1996","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"c70","DOI":"10.1159\/000108641","article-title":"Frusemide Administration in Critically Ill Patients by Continuous Compared to Bolus Therapy","volume":"107","author":"Ostermann","year":"2007","journal-title":"Nephron Clin. Pract."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.2146\/ajhp090068","article-title":"Management of loop diuretic resistance in the intensive care unit","volume":"66","author":"Asare","year":"2009","journal-title":"Am. J. Heal. Pharm."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Salvador, D., Rey, N., Ramos, G., and Punzalan, F. (2004). Continuous infusion versus bolus injection of loop diuretics in congestive heart failure. Cochrane Database of Systematic Reviews, John Wiley & Sons, Ltd.","DOI":"10.1002\/14651858.CD003178.pub2"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/jphp.12647","article-title":"Physical compatibility of total parenteral nutrition and drugs in Y-site administration to children from neonates to adolescents","volume":"69","author":"Staven","year":"2017","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1177\/0148607112464239","article-title":"Compatibility of intravenous medications with parenteral nutrition: In vitro evaluation","volume":"37","author":"Bouchoud","year":"2013","journal-title":"JPEN J. Parenter. Enteral Nutr."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/014860719902300267","article-title":"Compatibility of medications with 3-in-1 parenteral nutrition admixtures","volume":"23","author":"Trissel","year":"1999","journal-title":"J. Parenter. Enter. Nutr."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e15747","DOI":"10.1097\/MD.0000000000015747","article-title":"Evaluation of Y-site compatibility of home total parenteral nutrition and intravenous loop diuretics","volume":"98","author":"Watrobska","year":"2019","journal-title":"Med. Baltim."},{"key":"ref_32","unstructured":"European Pharmacopoeia (2017). Parenteral preparations 2017. European Pharmacopoeia (Ph. Eur.), EDQM. [9th ed.]."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Tomczak, S., Stawny, M., Dettlaff, K., Kieliszek, M., S\u0142omi\u0144ska, D., and Jeli\u0144ska, A. (2019). Physicochemical Compatibility and Stability of Linezolid with Parenteral Nutrition. Molecules, 24.","DOI":"10.3390\/molecules24071242"},{"key":"ref_34","unstructured":"USP (2009). Globule Size Distribution in Lipid Injectable Emulsions, The United states Pharmacopeia 33\/National Formulary."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.foodres.2012.07.036","article-title":"Hydrolysis of native milk fat globules by microbial lipases: Mechanisms and modulation of interfacial quality","volume":"49","author":"Bourlieu","year":"2012","journal-title":"Food Res. Int."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1023\/A:1018932421357","article-title":"The influence of free fatty acid formation on the pH of phospholipid-stabilized triglyceride emulsions","volume":"10","author":"Herman","year":"1993","journal-title":"Pharm. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1007\/s11095-006-9092-4","article-title":"Lipid injectable emulsions: Pharmacopeial and safety issues","volume":"23","author":"Driscoll","year":"2006","journal-title":"Pharm. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e134","DOI":"10.1016\/j.eclnm.2009.01.008","article-title":"Basics in clinical nutrition: Drugs and nutritional admixtures","volume":"4","year":"2009","journal-title":"E. Spen. Eur. e-J. Clin. Nutr. Metab."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Veltri, M., and Lee, C.K.K. (1996). Compatibility of neonatal parenteral nutrient solutions with selected intravenous drugs. Am. J. Health Syst. Pharm., 53.","DOI":"10.1093\/ajhp\/53.21.2611"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Trissel, L.A., Gilbert, D.L., Martinez, J.F., Baker, M.B., Walter, W.V., and Mirtallo, J.M. (1997). Compatibility of Parenteral Nutrient Solutions with Selected Drugs During Simulated Y-Site Administration, Oxford Academic.","DOI":"10.1093\/ajhp\/54.11.1295"},{"key":"ref_41","first-page":"48","article-title":"Y-Site Compatibility of Medications with Parenteral Nutrition","volume":"14","author":"Robinson","year":"2009","journal-title":"J. Pediatr. Pharmacol. Ther. JPPT"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1177\/0148607114521833","article-title":"A.S.P.E.N. Clinical Guidelines","volume":"38","author":"Boullata","year":"2014","journal-title":"J. Parenter. Enter. Nutr."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Reber, E., Messerli, M., Stanga, Z., and M\u00fchlebach, S. (2019). Pharmaceutical Aspects of Artificial Nutrition. J. Clin. Med., 8.","DOI":"10.3390\/jcm8112017"}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/12\/11\/1092\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:33:07Z","timestamp":1760178787000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/12\/11\/1092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,13]]},"references-count":43,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11]]}},"alternative-id":["pharmaceutics12111092"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics12111092","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,13]]}}}